5/24/2023 0 Comments Dr rudolph tanzi super brain“As an expert clinical scientist in the field of neurodegenerative disorders, with over three decades of outstanding research accomplishments in Alzheimer’s disease (AD), Dr. Rudy Tanzi has joined our scientific advisory board,” stated Eugene Williams, ProMIS Executive Chairman. Kennedy Professor of Neurology at Harvard University and Vice-Chair of Neurology, Director of the Genetics and Aging Research Unit, and Co-Director of the Henry and Allison McCance Center for Brain Health at Massachusetts General Hospital. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics selectively targeting toxic oligomers implicated in the development of neurodegenerative diseases, today announced the appointment of Rudolph Tanzi, Ph.D., to the Company’s scientific advisory board (SAB). 17, 2018 (GLOBE NEWSWIRE) - ProMIS Neurosciences, Inc.
0 Comments
Leave a Reply. |